Omkar Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve 1. Unaudited Financial ....

OMKAR SPECIALITY CHEMICALS LIMITED Registered Office:- INNOVS Boston House CTS 261, 7th Floor, Boston House Suren Road, Village Gundavli Next to Cinemax Cinema Mumbai- 400093, CIN: L24110MH2005PLC151589 OMIKERR Email:- omkar @kshitijpolyline.co.in Web:- www.omkarchemcicals.com Mobile:+-91 90818 72449 Always the leaders Date: 04/08/2026 The Bombay Stock Exchange Limited The National Stock Exchange Limited Corporate Relationship Department, Exchange Plaza, Bandra - Kurla Complex, 1st Floor, New Trading Ring, P] Tower, Bandra East, Mumbai - 400 059 Dalal Street, Mumbai - 400 001 Script Code: 533317 NSE Symbol: OMKARCHEM Script Name: OMKARCHEM Subject: Prior Intimation under Regulation 29 of the Securities and Exchange Board of India (Listin; Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the meeting of Board of Directors of the company will be held on Friday, August 07,2026 to consider and approve the following matter: 1. Unaudited Financial Statements of the Company for the quarter September-2022, December 2022 and Audited Financial Statements for the year ended on March 31, 2023. 2. Unaudited Financial Statements of the Company for all the quarter and Audited Financial Statements for the year ended on March 31, 2024. 3. Unaudited Financial Statements of the Company for all the quarter and Audited Financial Statements for the year ended on March 31, 2025. As the exchange is aware that the company was under Corporate Insolvency Resolution Process under the provisions of Insolvency and Bankruptcy Code, 2016, the company was not able to submit its Quarterly/Half Yearly/Yearly financial results from the financial year 2022 to 2025. The delay was primarily attributable to circumstances prevailing during the CIRP, including, inter alia, resignation of Key Managerial Personnel, non-availability of records and other operational constraints. Please be informed that tradingin the equity shares of the Company has remained suspended on BSE Limited and the National Stock Exchange of India Limited. In view of the continuing suspension of trading, the Company has not issued a separate intimation regarding the closure of the Trading Window in connection with the aforesaid Board Meeting, as the securities of the Company are presently not available for trading on the Stock Exchanges. This is for your information and records. Thanking you, Yours Faithfully, For OmKar Speciality Chemicals Limited MAHENDRA n2ievs os Date: 20260808 KUMARJAIN 353350 Mahendra Kumar Jain Additional Director DIN: 09765526